Rankings
▼
Calendar
BHVN Q2 2021 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena
BHVN
Biohaven Ltd.
$1B
Q2 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$93M
+858.3% YoY
Gross Profit
$76M
81.3% margin
Operating Income
-$172M
-185.0% margin
Net Income
-$211M
-226.6% margin
EPS (Diluted)
$-3.23
QoQ Revenue Growth
+112.1%
Cash Flow
Operating Cash Flow
-$35M
Free Cash Flow
-$35M
Stock-Based Comp.
$19M
Balance Sheet
Total Assets
$846M
Total Liabilities
$1.2B
Stockholders' Equity
-$454M
Cash & Equivalents
$306M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$93M
$10M
+858.3%
Gross Profit
$76M
$7M
+1038.5%
Operating Income
-$172M
-$161M
-7.0%
Net Income
-$211M
-$181M
-16.4%
← FY 2021
All Quarters
Q3 2021 →